Immunosuppressive Effects of Tautomycetin on T Cells.
- Author:
Heug Kyu LEE
;
Kyung Min CHO
;
Hyoung Sik CHUN
;
Hyeog Jin SON
;
Sang Kyou LEE
- Publication Type:Original Article
- Keywords:
Tautomycetin;
Immunosuppressive drug;
IL-2;
MLR;
Concanavalin A
- From:Korean Journal of Immunology
1998;20(2):85-90
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
T cell activation is a critical event for initiation and regulation of immune responses and inhibitors of such signaling pathways are clinically useful for the treatment of patients received allogratt and autoimmune disease. In the course of screening soil microorganisms from the forest of Cheju island in Korea for new immunosuppressive agent, one of Streptomyces species (CK-95441) was found to produce a new immunosuppressant, tautomycetin which also had antifungal activity. Tautomycetin showed the inhibition of T cell proliferation in murine mixed lymphocyte reaction (MLR) and T cell activation induced by concanavalin A. Tautomycetin also blocked the induction of IL-2 gene expression which was examined in Jurkat TAg cell line in which multiple NFAT-binding sites and minimal IL-2 promoter drive the production of B-galactosidase. Also, the level of inhibition in activation-induced IL-2 receptor expression by tautomycetin was greater than those by cyclosporin A measured by flow cytometry. But, Fas ligand-induced apoptosis in Jurkat cells was unaffected by tautomycetin which was measured by DNA fragmentation assay. These results suggested that tautomycetin will be able to be used as a potent immunosuppressive drug following organ transplantation.
